Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
RAS Mutational Status in Advanced Colorectal Adenocarcinoma Treated With Anti-angiogenics: Preliminary Experience With Liquid Biopsy.
DE Santiago BG, López-Gómez M, Delgado-López PD, Gordo AJ, Neria F, Thuissard-Vasallo IJ, Gómez-Raposo C, Tevar FZ, Moreno-Rubio J, Hernández AM, Iglesias I, Casado E. DE Santiago BG, et al. Among authors: moreno rubio j. In Vivo. 2021 Sep-Oct;35(5):2841-2844. doi: 10.21873/invivo.12571. In Vivo. 2021. PMID: 34410976 Free PMC article.
Analysis of the concordance in the EGFR pathway status between primary tumors and related metastases of colorectal cancer patients:implications for cancer therapy.
Cejas P, López-Gómez M, Aguayo C, Madero R, Moreno-Rubio J, de Castro Carpeño J, Belda-Iniesta C, Barriuso J, Moreno García V, Díaz E, Burgos E, Gonzalez-Barón M, Feliu J. Cejas P, et al. Curr Cancer Drug Targets. 2012 Feb;12(2):124-31. doi: 10.2174/156800912799095162. Curr Cancer Drug Targets. 2012. PMID: 22229245
Upregulation of trefoil factor 3 (TFF3) after rectal cancer chemoradiotherapy is an adverse prognostic factor and a potential therapeutic target.
Casado E, Garcia VM, Sánchez JJ, Gómez Del Pulgar MT, Feliu J, Maurel J, Castelo B, Moreno Rubio J, López RA, García-Cabezas MÁ, Burgos E, de Castro J, Belda-Iniesta C, López-Gómez M, Gómez-Raposo C, Zambrana F, Sereno M, Fernández-Martos C, Vázquez P, Lacal JC, González-Barón M, Cejas P. Casado E, et al. Int J Radiat Oncol Biol Phys. 2012 Dec 1;84(5):1151-8. doi: 10.1016/j.ijrobp.2012.01.083. Epub 2012 Apr 18. Int J Radiat Oncol Biol Phys. 2012. PMID: 22516806
MYH polyposis syndrome: clinical findings, genetics issues and management.
Sereno M, Merino M, López-Gómez M, Gómez-Raposo C, Zambrana Tébar F, Moreno Rubio J, Espinós J, Martín-Algarra S, Casado Sáenz E. Sereno M, et al. Clin Transl Oncol. 2014 Aug;16(8):675-9. doi: 10.1007/s12094-014-1171-0. Epub 2014 Mar 19. Clin Transl Oncol. 2014. PMID: 24643704 Review.
Gene expression differences in primary colorectal tumors and matched liver metastases: chemotherapy related or tumoral heterogeneity?
López-Gómez M, Moreno-Rubio J, Suárez-García I, Cejas P, Madero R, Casado E, Jiménez AM, Sereno M, Gómez-Raposo C, Zambrana F, Merino M, Fernández-Luengas D, Feliu J. López-Gómez M, et al. Clin Transl Oncol. 2015 Apr;17(4):322-9. doi: 10.1007/s12094-014-1233-3. Epub 2014 Oct 10. Clin Transl Oncol. 2015. PMID: 25301403
Lipid metabolism and lung cancer.
Merino Salvador M, Gómez de Cedrón M, Moreno Rubio J, Falagán Martínez S, Sánchez Martínez R, Casado E, Ramírez de Molina A, Sereno M. Merino Salvador M, et al. Crit Rev Oncol Hematol. 2017 Apr;112:31-40. doi: 10.1016/j.critrevonc.2017.02.001. Epub 2017 Feb 13. Crit Rev Oncol Hematol. 2017. PMID: 28325263 Review.
Antinuclear antibodies and cancer: A literature review.
Vlagea A, Falagan S, Gutiérrez-Gutiérrez G, Moreno-Rubio J, Merino M, Zambrana F, Casado E, Sereno M. Vlagea A, et al. Crit Rev Oncol Hematol. 2018 Jul;127:42-49. doi: 10.1016/j.critrevonc.2018.05.002. Epub 2018 May 26. Crit Rev Oncol Hematol. 2018. PMID: 29891110 Review.
37 results